Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with small cell lung cancer and cytotoxic T-cell-mediated pathology: Case report

Anti-N-methyl-D-aspartate receptor (NMDAR) antibody encephalitis is caused by a reversible inhibition of ion channel actions by autoantibodies and is associated with a relatively good prognosis. Pathological findings of NMDAR encephalitis usually do not show neurophagorous nodules, but rare or mild...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 13
Main Authors Akanuma, Haruna, Iizuka, Takahiro, Abe, Dan, Yoshida, Kenji, Matsuda, Nozomu, Sugimoto, Kotaro, Hashimoto, Yuko, Kanai, Kazuaki
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 19.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Anti-N-methyl-D-aspartate receptor (NMDAR) antibody encephalitis is caused by a reversible inhibition of ion channel actions by autoantibodies and is associated with a relatively good prognosis. Pathological findings of NMDAR encephalitis usually do not show neurophagorous nodules, but rare or mild inflammatory infiltration. We report a patient of small cell lung cancer (SCLC)-related paraneoplastic encephalitis with NMDAR antibodies, a cytotoxic T-cell-mediated pathology of the brain, and a rapid clinical course. This case highlights that the neuropathological diversity of NMDAR encephalitis may be even broader than previously thought and that NMDAR antibodies may also be found in various pathological conditions with a vigorous immune response.
Bibliography:Edited by: Robert Weissert, University of Regensburg, Germany
Reviewed by: Hongjun Hao, Peking University First Hospital, China; Sergio Muñiz-Castrillo, Stanford Center for Sleep Sciences and Medicine, United States
This article was submitted to Multiple Sclerosis and Neuroimmunology, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.952868